Capital Growth’s BioBank Acquired by NewAlpha Verto

0

Capital Croissance sold its majority stake BioBank to NewAlpha Verto Capital and its team. NewAlpha selects, finances and accompanies innovative entrepreneurial projects, primarily in asset management and other related sectors such as financial technologies or services for investment management firms.

Bionest supported BIOBank and Capital Croissance towards the deal by performing a vendor due diligence of BIOBank. The team was led by Alain Gilbert, co-founder of Bionest Partners, who has already supported numerous Life Sciences companies through similar processes and Maëlle Bruneau, Senior Consultant

 

 

Leave A Reply

Your email address will not be published.